安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Home - Cognoa
Cognoa is an early childhood development and pediatric behavioral health company developing digital diagnostics and therapeutics to enable earlier and more equitable access to care that improves the lives and outcomes of children and families
- Cognoa: AI in Autism Diagnosis
By leveraging the power of artificial intelligence, Cognoa is poised to transform the landscape of ASD diagnosis and support Cognoa’s ASD diagnosis aid is a revolutionary digital tool designed to assist healthcare professionals in identifying autism in children as young as 18 months old
- Cognoas AI-powered diagnostic app for autism clears clinical study . . .
Cognoa aims to equip primary care pediatricians with an artificial-intelligence-powered digital app that can spot the signs of autism, allowing them to rule out or diagnose spectrum disorders
- FDA Authorizes Marketing of Diagnostic Aid for Autism Spectrum Disorder
The Cognoa ASD Diagnosis Aid is a machine learning-based software intended to help health care providers diagnose ASD in children 18 months through 5 years of age who exhibit potential
- DE NOVO CLASSIFICATION R COGNOA ASD D A - Food and Drug Administration
The Cognoa ASD Diagnosis Aid is intended for use by healthcare providers as an aid in the diagnosis of Autism Spectrum Disorder (ASD) for patients ages 18 months through 72 months who are at
- Cognoa preps FDA filing for digital autism diagnostic
An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with
- Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and . . .
Cognoa, a company at the forefront of digital behavioral health for children, today announces it has received Breakthrough Device designations from the U S Food and Drug Administration (FDA) for its lead products, the first digital diagnostic and digital therapeutic devices for autism
- Cognoa’s Canvas Dx Aids In Early Diagnosis Of ASD
Biotechnology company Cognoa has developed the Canvas Dx platform to aid ASD diagnosis through a machine learning algorithm that assesses data from caregivers, healthcare providers, and portal specialists
|
|
|